These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32442644)

  • 21. Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy.
    Ray E; Vaghasiya K; Sharma A; Shukla R; Khan R; Kumar A; Verma RK
    AAPS PharmSciTech; 2020 Sep; 21(7):260. PubMed ID: 32944787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy.
    Ma R; Ma ZG; Gao JL; Tai Y; Li LJ; Zhu HB; Li L; Dong DL; Sun ZJ
    J Biomed Mater Res A; 2020 Jan; 108(1):30-38. PubMed ID: 31433913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells.
    Choi JS; Park JS
    Colloids Surf B Biointerfaces; 2017 Nov; 159():139-150. PubMed ID: 28783505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antineoplastic mechanisms of niclosamide-loaded nanoparticles in human colorectal cancer cells].
    Zhirnik AS; Semochkina YP; Moskaleva EY; Krylov NI; Tubasheva IA; Kuznetsov SL; Vorontsov EA
    Biomed Khim; 2017 Mar; 63(2):132-138. PubMed ID: 28414284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
    Rarokar NR; Khedekar PB; Bharne AP; Umekar MJ
    Int J Biol Macromol; 2019 Mar; 125():1056-1068. PubMed ID: 30572051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
    Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
    Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery.
    Elghazawy NH; Hefnawy A; Sedky NK; El-Sherbiny IM; Arafa RK
    Eur J Pharm Sci; 2017 Jul; 105():203-211. PubMed ID: 28526600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities.
    Barbosa EJ; Löbenberg R; de Araujo GLB; Bou-Chacra NA
    Eur J Pharm Biopharm; 2019 Aug; 141():58-69. PubMed ID: 31078739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoliposomal Encapsulation Enhances
    Hatamipour M; Jaafari MR; Momtazi-Borojeni AA; Ramezani M; Sahebkar A
    Anticancer Agents Med Chem; 2019; 19(13):1618-1626. PubMed ID: 31284876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
    Park JE; Park J; Jun Y; Oh Y; Ryoo G; Jeong YS; Gadalla HH; Min JS; Jo JH; Song MG; Kang KW; Bae SK; Yeo Y; Lee W
    J Control Release; 2019 May; 302():148-159. PubMed ID: 30954620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the physical and chemical stability of niclosamide crystal forms in aqueous versus nonaqueous suspensions.
    de Villiers MM; Mahlatji MD; van Tonder EC; Malan SF; Lötter AP; Liebenberg W
    Drug Dev Ind Pharm; 2004 Jul; 30(6):581-92. PubMed ID: 15285331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
    Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
    Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
    Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
    Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis.
    Gyamfi J; Lee YH; Min BS; Choi J
    Sci Rep; 2019 Aug; 9(1):11336. PubMed ID: 31383893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
    Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
    Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.